Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 1/20 | 0.65 |
| ▸ | PDE10A | Q9Y233 | 6/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.54 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | HTR7 | P34969 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | PRKACA | P17612 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31705085 | 0.88 | RAB9A (0.56) | MEN1KMT2ARAB9APDE10AKCNH2 | |
| SCHEMBL27651070 | 0.88 | MEN1 (0.56) | MEN1KMT2ARAB9APDE10AKCNH2 | |
| SCHEMBL12576617 | 0.88 | RAB9A (0.56) | MEN1KMT2ARAB9APDE10AKCNH2 | |
| SCHEMBL5645917 | 0.86 | MEN1 (0.65) | MEN1KMT2ARAB9APDE10AKCNH2 | |
| SCHEMBL28067777 | 0.86 | PDE10A (0.49) | MEN1KMT2ARAB9APDE10AKCNH2 | |
| SCHEMBL31249572 | 0.85 | KCNH2 (0.56) | MEN1KMT2ARAB9APDE10AKCNH2 | |
| SCHEMBL17261488 | 0.83 | MEN1 (0.50) | MEN1KMT2ARAB9APDE10AASIC3 | |
| SCHEMBL3854280 | 0.83 | MEN1 (0.50) | MEN1KMT2ARAB9APDE10AKCNH2 | |
| SCHEMBL7453825 | 0.83 | PDE10A (0.66) | MEN1KMT2ARAB9APDE10AKCNH2 | |
| SCHEMBL2953474 | 0.83 | MEN1 (0.60) | MEN1KMT2ARAB9APDE10AASIC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| EP-1683804-A2 | PLATINUM COMPLEX AND LUMINESCENT ELEMENT | Takasago International Corporation (JP) | 2006-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070103060-A1 | Platinum complex and light emitting device | UBE2D3, PCID2, CCND2 | MEN1 1473/4885KMT2A 1827/4885RAB9A 1399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.